載入...

Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists

The inflammatory Bowel diseases (IBDs) are a chronic, relapsing inflammatory diseases of the gastrointestinal tract with heterogeneous behavior and prognosis. The introduction of biological therapies including anti-TNF, anti-IL-12/23, and anti-integrins, has revolutionized the treatment of IBD, but...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Tamara Pérez-Jeldres, Christopher J. Tyler, Joshua D. Boyer, Thangaraj Karuppuchamy, Andrés Yarur, Daniel A. Giles, Shaila Yeasmin, Luke Lundborg, William J. Sandborn, Derek R. Patel, Jesús Rivera-Nieves
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2019-03-01
叢編:Frontiers in Pharmacology
主題:
IBD
MOA
在線閱讀:https://www.frontiersin.org/article/10.3389/fphar.2019.00212/full
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!